SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010124
Filing Date
2020-08-10
Accepted
2020-08-10 14:05:34
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bstc-20200630x10q.htm   iXBRL 10-Q 1297550
2 EX-10.5 bstc-20200630xex10d5.htm EX-10.5 30593
3 EX-10.6 bstc-20200630xex10d6.htm EX-10.6 170428
4 EX-31.1 bstc-20200630xex31d1.htm EX-31.1 14434
5 EX-31.2 bstc-20200630xex31d2.htm EX-31.2 14221
6 EX-32.1 bstc-20200630xex32d1.htm EX-32.1 8017
  Complete submission text file 0001558370-20-010124.txt   6081795

Data Files

Seq Description Document Type Size
7 EX-101.SCH bstc-20200630.xsd EX-101.SCH 31181
8 EX-101.CAL bstc-20200630_cal.xml EX-101.CAL 39750
9 EX-101.DEF bstc-20200630_def.xml EX-101.DEF 154627
10 EX-101.LAB bstc-20200630_lab.xml EX-101.LAB 395347
11 EX-101.PRE bstc-20200630_pre.xml EX-101.PRE 302034
12 EXTRACTED XBRL INSTANCE DOCUMENT bstc-20200630x10q_htm.xml XML 1110965
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19879 | Film No.: 201088741
SIC: 2834 Pharmaceutical Preparations